ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 113 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $4,213 | -74.7% | 1,685 | -79.5% | 0.00% | – |
| Q3 2023 | $16,670 | -57.8% | 8,212 | -52.2% | 0.00% | – |
| Q2 2023 | $39,509 | -40.8% | 17,178 | -22.0% | 0.00% | – |
| Q1 2023 | $66,733 | +42.0% | 22,024 | +42.3% | 0.00% | -100.0% |
| Q2 2021 | $47,000 | -88.3% | 15,474 | -87.2% | 0.00% | -83.3% |
| Q1 2021 | $401,000 | -70.6% | 120,529 | -68.6% | 0.01% | -68.4% |
| Q4 2020 | $1,364,000 | +957.4% | 384,297 | +835.6% | 0.02% | +850.0% |
| Q3 2020 | $129,000 | +20.6% | 41,074 | -30.3% | 0.00% | 0.0% |
| Q2 2020 | $107,000 | +143.2% | 58,913 | +34.1% | 0.00% | 0.0% |
| Q1 2020 | $44,000 | -90.5% | 43,919 | -73.6% | 0.00% | -85.7% |
| Q4 2019 | $462,000 | – | 166,138 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,651,825 | $19,358,000 | 6.60% |
| RTW INVESTMENTS, LP | 5,165,499 | $37,708,000 | 2.72% |
| Eversept Partners, LP | 97,495 | $711,714 | 0.33% |
| Seelaus Asset Management LLC | 14,300 | $104,000 | 0.09% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,765,315 | $8,827,000 | 0.08% |
| ALGERT GLOBAL LLC | 34,816 | $254,000 | 0.05% |
| BOOTHBAY FUND MANAGEMENT, LLC | 48,000 | $350,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 211,115 | $1,540,000 | 0.03% |
| PRIMECAP MANAGEMENT CO/CA/ | 4,000,400 | $29,203,000 | 0.02% |
| PDT Partners, LLC | 66,965 | $489,000 | 0.02% |